Reproductive Outcomes in Patients with Infertility and Insulin Resistance
Main Article Content
Abstract
Infertility defined as the inability of a couple to achieve conception after one year of sexual intercourse without contraceptive protection, or after 6 months in patients older than 35 years. According to the WHO, 10-15% of couples have some fertility problem and 25-50% of this is due to anovulatory female infertility, which could be due to insulin resistance, especially in overweight and obese patients, since 75% of obese patients suffer from IR, added to the fact that overweight and obesity have a high prevalence in the Mexican population, where a prevalence of up to 35% has been reported, it is important to consider it as a causal factor in patients with infertility. In 2021, 413 first-time patients with a diagnosis of infertility were received at the Gynecology-Obstetrics UMAE of CMNO IMSS; of these, 245 have a diagnosis of anovulation and about 40% are overweight or obese, however, there is no report on reproductive outcomes of these patients who undergo medical treatment, some cases achieve clinical pregnancy and of these some result in term births, preterm, miscarriage and / or death.
Infertility and obesity have a great impact on women's health, affecting the physical, psychological, family and social area, leading to a deterioration in the quality of life, in turn obesity is one of the main risk factors for numerous diseases, so they are of special interest to social level and in the health system, being important its study and treatment to achieve better results of fertility and health in general.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Carson SA, Kallen AN. Diagnosis and Management of Infertility. JAMA. 2021 Jul 6;326(1):65.
II. Breitkopf DM, Member A, Hill M. ACOG COMMITTEE OPINION Infertility Workup for the Women’s Health Specialist [Internet]. Available from:http://www.choosingwisely.org/wp-content/uploads/2015/02/
III. Sills ES, Perloe M, Palermo GD. Correction of hyperinsulinemia in oligoovulatory women with clomiphene-resistant polycystic ovary syndrome: a review of therapeutic rationale and reproductive outcomes. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2000 Aug;91(2):135–41.
IV. Sakumoto T, Tokunaga Y, Tanaka H, Nohara M, Motegi E, Shinkawa T, et al. Insulin resistance/hyperinsulinemia and reproductive disorders in infertile women. Reprod Med Biol. 2010 Dec;9(4):185–90.
V. Tian L, Shen H, Lu Q, Norman RJ, Wang J. Insulin Resistance Increases the Risk of Spontaneous Abortion after Assisted Reproduction Technology Treatment. J Clin Endocrinol Metab. 2007 Apr 1;92(4):1430–3.
VI. Dhont M. WHO-classification of anovulation: background, evidence and problems. Int Congr Ser. 2005 Apr;1279:3–9.
VII. Brower M, Brennan K, Pall M, Azziz R. The Severity of Menstrual Dysfunction as a Predictor of Insulin Resistance in PCOS. J Clin Endocrinol Metab. 2013 Dec;98(12):E1967–71.
VIII. Gorczyca AM, Steger FL, Ptomey LT, Montgomery RN, Mickelsen R, Smith P, et al. The impact of a group based, remotely delivered weight loss intervention in women with polycystic ovary syndrome on ovulation, quality of life and body composition. Frontiers in Reproductive Health. 2022 Jul 22;4.
IX. Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012 Jan;97(1):28-38.e25.
X. Bergh CM, Moore M, Gundell C. Evidence-Based Management of Infertility in Women With Polycystic Ovary Syndrome. JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing. 2016 Jan 1;45(1):111–22.
XI. Yu Q, Hu S, Wang Y, Cheng G, Xia W, Zhu C. Letrozole versus laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reproductive Biology and Endocrinology. 2019 Dec 6;17(1):17.
XII. Role of tubal surgery in the era of assisted reproductive technology: a committee opinion. Fertil Steril. 2015 Jun;103(6):e37–43.
XIII. Pérez-Medina T, Bajo-Arenas J, Salazar F, Redondo T, Sanfrutos L, Alvarez P, et al. Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study. Human Reproduction. 2005 Jun 1;20(6):1632–5.
XIV. Metwally M, Raybould G, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database of Systematic Reviews. 2020 Jan 29;2020(1).
XV. Bosteels J, van Wessel S, Weyers S, Broekmans FJ, D’Hooghe TM, Bongers MY, et al. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database of Systematic Reviews. 2018 Dec 5;2018(12).
XVI. Metwally M, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database of Systematic Reviews. 2012 Nov 14;
XVII. Zolton JR, Lindner PG, Terry N, DeCherney AH, Hill MJ. Gonadotropins versus oral ovarian stimulation agents for unexplained infertility: a systematic review and meta-analysis. Fertil Steril. 2020 Feb;113(2):417-425.e1.
XVIII. WHO Consultation on Obesity (1999: Geneva S& WHO. Obesity : preventing and managing the global epidemic : report of a WHO consultation. World Health Organization. World Health Organization. 2000;
XIX. Manuel Moreno G. Definición y clasificación de la obesidad. Revista Médica Clínica Las Condes. 2012 Mar;23(2):124–8.
XX. Shamah Levy T, Romero Martínez M, Barrientos Gutiérrez T, Cuevas-Nasu L, Bautista Arredondo S, Colchero MA, et al. Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19. Resultados nacionales. Instituto Nacional de Salud Pública. 2021;
XXI. Glenn T, Harris AL, Lindheim SR. Impact of obesity on male and female reproductive outcomes. Curr Opin Obstet Gynecol. 2019 Aug;31(4):201–6.
XXII. Jungheim ES, Moley KH. Current knowledge of obesity’s effects in the pre- and periconceptional periods and avenues for future research. Am J Obstet Gynecol. 2010 Dec;203(6):525–30.
XXIII. Ahmad R, Haque M. Obesity: A Doorway to a Molecular Path Leading to Infertility. Cureus. 2022 Oct 27;
XXIV. Fernando Carrasco N, José Eduardo Galgani F, Marcela Reyes J. Síndrome de resistencia a la insulina. estudio y manejo. Revista Médica Clínica Las Condes. 2013 Sep;24(5):827–37.
XXV. Santillana Espinosa E, Ávila Esquivel F. Infertilidad e insulinorresistencia. Archivos de investigación Materno Infantil. 2009 Sep;I(3):118–22.
XXVI. Consenso Mexicano de Resistencia a la Insulina y Síndrome Metabólico. Rev Mex Cardiol . 1999 Jan;10(1):3–19.
XXVII. Armanini D, Boscaro M, Bordin L, Sabbadin C. Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism. Int J Mol Sci. 2022 Apr 8;23(8):4110.
XXVIII. Sekulovski N, Whorton AE, Shi M, Hayashi K, MacLean JA. Periovulatory insulin signaling is essential for ovulation, granulosa cell differentiation, and female fertility. The FASEB Journal. 2020 Feb 12;34(2):2376–91.
XXIX. Pérez Peña E. Atencion integral de la infertilidad : endocrinología, cirugía y reproducción asistida. Cuarta edición. Ciudad de México: Editorial Médica Panamericana; 2020. 0–1011 p.
XXX. Baskind NE, Balen AH. Hypothalamic–pituitary, ovarian and adrenal contributions to polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2016 Nov;37:80–97.
XXXI. Vanhauwaert PS. Síndrome de ovario poliquístico e infertilidad. Revista Médica Clínica Las Condes. 2021 Mar;32(2):166–72.
XXXII. Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, Orlova C, et al. Serum Adiponectin Levels Are Inversely Associated with Overall and Central Fat Distribution but Are Not Directly Regulated by Acute Fasting or Leptin Administration in Humans: Cross-Sectional and Interventional Studies. J Clin Endocrinol Metab. 2003 Oct;88(10):4823–31.
XXXIII. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010 Jan 1;91(1):258S-261S.
XXXIV. Roitberg GE, Dorosh Zh v., Sharkhun OO. A New Method for Screening Diagnosis of Insulin Resistance. Bull Exp Biol Med. 2015 Jan 9;158(3):397–400.
XXXV. Mora Morales EricVFM V. Consideraciones clínicas sobre la importancia de la sensibilidad a la insulina, su resistencia y la intolerancia a la glucosa. Asociación Latinoamericana de Diabetes. 2007 Sep 19;15(2):67–72.
XXXVI. Rask Larsen J, Dima L, Correll CU, Manu P. The pharmacological management of metabolic syndrome. Expert Rev Clin Pharmacol. 2018 Apr 3;11(4):397–410.
XXXVII. Genazzani AD, Chierchia E, Rattighieri E, Santagni S, Casarosa E, Luisi M, et al. Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS. Gynecological Endocrinology. 2010 Sep 12;26(9):684–9.
XXXVIII. Elsenbruch S, Hahn S, Kowalsky D, Öffner AH, Schedlowski M, Mann K, et al. Quality of Life, Psychosocial Well-Being, and Sexual Satisfaction in Women with Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2003 Dec 1;88(12):5801–7.
XXXIX. Facchinetti F, Unfer V, Dewailly D, Kamenov ZA, Diamanti-Kandarakis E, Laganà AS, et al. Inositols in Polycystic Ovary Syndrome: An Overview on the Advances. Trends in Endocrinology & Metabolism. 2020 Jun;31(6):435–47.
XL. Fertility problems: assessment and treatment Clinical guideline [Internet]. 2013. Available from: www.nice.org.uk/guidance/cg156
XLI. Cunha A, Póvoa AM. Infertility management in women with polycystic ovary syndrome: a review. Porto Biomed J. 2021 Jan;6(1):e116.
XLII. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008 Mar;89(3):505–22.
XLIII. Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: An analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016 Nov 1;22(6):687–708.
XLIV. Wang R, Li W, Bordewijk EM, Legro RS, Zhang H, Wu X, et al. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis. Hum Reprod Update. 2019 Nov 5;25(6):717–32.
XLV. Weiss NS, Kostova E, Nahuis M, Mol BWJ, van der Veen F, van Wely M. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews. 2019 Jan 16;
XLVI. Mandelbaum RS, Agarwal R, Violette C, Anderson Z, Melville SJF, McGinnis LK, et al. what is the ideal letrozole regimen for ovulation induction in women with polycystic ovary syndrome? Fertil Steril. 2022 Oct;118(4):e217.
XLVII. Pandya MR, Patel K. A study of comparison of effectiveness of letrozole (5mg) versus Clomiphene citrate (100 mg) for ovulation induction among infertile women. Indian J Obstet Gynecol Res . 2021 Nov;8(4):553–8.
XLVIII. Mejia RB, Summers KM, Kresowik JD, van Voorhis BJ. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome. Fertil Steril. 2019 Mar;111(3):571-578.e1.
XLIX. Bahadur A, Modalavalasa SS, Mundhra R, Singh R, Chawla L, Chaturvedi J. P-688 Combination of letrozole and clomiphene citrate versus letrozole alone for ovulation induction in women with polycystic ovary syndrome - a randomized controlled trial. Human Reproduction. 2022 Jun 29;37(Supplement_1).
L. Cai WY, Luo X, Song J, Ji D, Zhu J, Duan C, et al. Effect of Hyperinsulinemia and Insulin Resistance on Endocrine, Metabolic, and Reproductive Outcomes in Non-PCOS Women Undergoing Assisted Reproduction: A Retrospective Cohort Study. Front Med (Lausanne). 2022 Jan 7;8.
LI. Wang H, Zhang Y, Fang X, Kwak-Kim J, Wu L. Insulin Resistance Adversely Affect IVF Outcomes in Lean Women Without PCOS. Front Endocrinol (Lausanne). 2021 Sep 6;12.
LII. Liu Y, Li J, Yan Z, Liu D, Ma J, Tong N. Improvement of Insulin Sensitivity Increases Pregnancy Rate in Infertile PCOS Women: A Systemic Review. Front Endocrinol (Lausanne). 2021 Mar 30;12.
LIII. Cunha A, Póvoa AM. Infertility management in women with polycystic ovary syndrome: a review. Porto Biomed J. 2021 Jan;6(1):e116.
LIV. Española RA. Real Academia Española. 2018;
LV. DeCherney AH, Nathan L, Laufer N, Roman AS. Diagnóstico y tratamiento ginecoobstétricos. 12th ed. 2019.
LVI. Report of a WHO Consultation. WHO. Obesity: preventing and managing the global epidemic. WHO Technical Report Series 894,.
LVII. Otoya Chaves F, León Quirós S, Rodríguez Morera M. Manejo de infertilidad por anovulación en síndrome de ovario poliquístico. Revista Medica Sinergia. 2021 Feb 1;6(2):e642.
LVIII. Barbieri RL. Induction of ovulation in infertile women with hyperandrogenism and insulin resistance. Am J Obstet Gynecol. 2000 Dec;183(6):1412-8.
LIX. Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity's impact. Fertil Steril. 2017 Apr;107(4):840-7.
LX. Toriello, C., Brunner-Mendoza, C., Ruiz-Baca, E. et al. Sporotrichosis in Mexico. Braz J Microbiol 52, 49–62 (2021). https://doi.org/10.1007/s42770-020-00387-x